https://www.selleckchem.com/pr....oducts/Elesclomol.ht
There are few data on the quality of EUS in the community setting. We characterized EUS performance at the individual facility level in 3 large American states, using need for repeat biopsy (NR as a metric for procedural failure, and the rate of unplanned hospital encounters (UHEs) as a metric for adverse events. We collected data on 76,614 EUS procedures performed at 166 facilities in California, Florida, and New York (2009-2014). The endpoints for the study were 7-day rate of UHEs after EUS, and 30-day rate of NRB after EUS with
Like
Comment
Share
